With the growing demand for personalized healthcare services and original biologics are scheduled to lose their patent by 2020, this has led to a subsequent rise in demand for drug research and to develop similar biologics (biosimilars). According to a recent report by ASSOCHAM-Sathguru, “biosimilars presents a US$240-billion global opportunity to Indian biopharmaceutical industry and the domestic market is expected to grow US$40 billion by 2030”. To facilitate drug research and development of new technologies, like bioanalytical testing, have been developed that has revolutionized the healthcare and biopharmaceutical industries. As per the latest report the Global Bioanalytical Testing Services Market is anticipated to mark 12.95% CAGR across the review period 2018 to 2023 to reach a valuation of USD 1867.30 million by 2023. This has intensified the demand for research & development across the pharmaceutical industry, which has proliferated the bioanalytical testing services market.
The high cost of bioanalytical testing has given the impetus to the outsourcing of analytical testing than in-house R&D; this has become a driving force for the market growth. The other factors that are adding numbers to the market growth are the increasing number of test techniques for better and accurate evaluation of the molecules or compounds. To get the accuracy in the drug development and validation, strict regulations are imposed by regulatory authorities that have raised the trend of outsourcing analytical testing upwards. Pertaining to this, understanding of regulation has become one of the most critical aspect of drug development and validation. However, the lack of skilled professionals in the field of bioanalytical, high rate of attrition, ambiguity in regulatory are some restraining reasons in the market growth.
In this limelight, CPhI Conferences is pleased to launch the premier edition of the “Biolytica – Analytical Outlook for Biopharma” scheduled for 23rd - 24th April 2020 in Hyderabad. A forum that will focus on the opportunities and gaps related to characterization, validation, regulation, technological advancement in the bioanalytical domain.